US Patent Issued to Celcuity on June 3 for "Methods of measuring signaling pathway activity for selection of therapeutic agents" (Minnesota Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,320,799, issued on June 3, was assigned to Celcuity Inc. (Minneapolis).

"Methods of measuring signaling pathway activity for selection of therapeutic agents" was invented by Lance Gavin Laing (Orono, Minn.) and Brian Francis Sullivan (Medina, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for simultaneously determining the functional status of multiple signaling pathways in a diseased cell sample obtained from a subject to thereby select for therapeutic use in the subject a targeted therapeutic agent that affects the signaling pathway with the highest level of aberrant activity in the subject's cells. Also provided are m...